Cargando…
A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
Tuberculosis chemotherapy is dependent on the use of the antibiotic pyrazinamide, which is being threatened by emerging drug resistance. Resistance is mediated through mutations in the bacterial gene pncA. Methods for testing pyrazinamide susceptibility are difficult and rarely performed, and this m...
Autores principales: | Yadon, Adam N., Maharaj, Kashmeel, Adamson, John H., Lai, Yi-Pin, Sacchettini, James C., Ioerger, Thomas R., Rubin, Eric J., Pym, Alexander S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605632/ https://www.ncbi.nlm.nih.gov/pubmed/28928454 http://dx.doi.org/10.1038/s41467-017-00721-2 |
Ejemplares similares
-
Structure guided prediction of Pyrazinamide resistance mutations in pncA
por: Karmakar, Malancha, et al.
Publicado: (2020) -
Pyrazinamide resistance of novel mutations in pncA and their dynamic behavior
por: Ali, Arif, et al.
Publicado: (2020) -
Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001) -
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia
por: Sengstake, Sarah, et al.
Publicado: (2017) -
Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
por: Shi, Dawei, et al.
Publicado: (2022)